JB Chemicals & Pharmaceuticals Limited — Board Meeting, 11-05-2026: Outcome of Board Meeting

J.B. Chemicals & Pharmaceuticals' board approved financial results for the year ended March 31, 2026. Consolidated revenue hit ₹4,148 Cr, net profit ₹709.5 Cr. A final dividend of ₹9.30/share was declared. The merger with Torrent Pharma, with a 51:100 share swap, received shareholder approval, now awaiting NCLT nod.